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Excitation–contraction couplingPrevious studies have shown that ventricular myocytes from female rats have smaller contractions and Ca2+
transients thanmales. As cardiac contraction is regulated by the cyclic adenosinemonophosphate (cAMP)/protein
kinase A (PKA) pathway, we hypothesized that sex differences in cAMP contribute to differences in Ca2+ han-
dling. Ca2+ transients (fura-2) and ionic currents were measured simultaneously (37 °C, 2 Hz) in ventricular
myocytes from adult male and female C57BL/6 mice. Under basal conditions, diastolic Ca2+, sarcoplasmic retic-
ulum (SR) Ca2+ stores, and L-type Ca2+ current did not differ between the sexes. However, femalemyocytes had
smaller Ca2+ transients (26% smaller), Ca2+ sparks (6% smaller), and excitation–contraction coupling gain in
comparison to males (23% smaller). Interestingly, basal levels of intracellular cAMP were lower in female
myocytes (0.7± 0.1 vs. 1.7± 0.2 fmol/μg protein; p b 0.001). Importantly, PKA inhibition (2 μMH-89) eliminat-
edmale–female differences in Ca2+ transients and gain, as well as Ca2+ spark amplitude.Western blots showed
that PKA inhibition also reduced the ratio of phospho:total RyR2 in male hearts, but not in female hearts. Stim-
ulation of cAMP production with 10 μM forskolin abolished sex differences in cAMP levels, as well as differences
in Ca2+ transients, sparks, and gain. To determine if the breakdown of cAMP differed between the sexes, phos-
phodiesterase (PDE) mRNA levels were measured. PDE3 expression was similar in males and females, but
PDE4B expressionwas higher in female ventricles. The inhibition of cAMP breakdown by PDE4 (10 μM rolipram)
abolished differences in Ca2+ transients and gain. These ﬁndings suggest that femalemyocytes have lower levels
of basal cAMPdue, in part, to higher expression of PDE4B. Lower cAMP levels in femalesmay attenuate PKAphos-
phorylation of Ca2+ handling proteins in females, and may limit positive inotropic responses to stimulation of
the cAMP/PKA pathway in female hearts.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Studies in humans have identiﬁed important differences in normal
cardiac contractile function between the sexes. For example, at rest,
women have a higher ejection fraction in comparison to men [1,2].
However, in response to exercise, men are able to increase their ejectionte; DMSO, dimethyl sulfoxide;
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. This is an open access article underfractionmore thanwomen [1,3]. These ﬁndings suggest thatwomen are
less able to augment contractile function in response to increasing
demand than men. The majority of studies with animal models concur
with these observations. Speciﬁcally, smaller contractions have been
reported in both working heart models and in cardiac muscles from
female animals in comparison to males, especially in conditions of
high demand such as increased pacing frequencies [4–7].
Previous studies in the ratmodel have found that these results trans-
late to isolatedmyocytes, in that cells from females exhibit smaller con-
tractions and Ca2+ transients in comparison to males, especially with
faster, more physiological stimulation frequencies (e.g. 1 to 4 Hz)
[8–10]. As sarcoplasmic reticulum (SR) Ca2+ release is lower in females,
but Ca2+ current is similar in both sexes, excitation–contraction (EC)
coupling gain is lower in myocytes from female rat hearts [8]. These
observations suggest that differences in Ca2+ regulation in individual
cardiomyocytes contribute to sex differences in cardiac contractile func-
tion. However, whether these can be generalized to other species isthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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coupling at the cellular level in other animal models.
Interestingly, although information is limited, some studies suggest
that there are also differences in responses to β-adrenergic receptor
stimulation in male and female cardiomyocytes. Activation of
β-adrenergic receptors is known to regulate EC coupling by increasing
production of cyclic adenosine monophosphate (cAMP), thus activating
protein kinase A (PKA) [11]. PKA phosphorylates various components of
the EC coupling pathway to increase inotropy and lusitropy [11]. Few
studies have examined sex differences in response to stimulation
of the cAMP/PKA pathway, and these studies have found that the
β-adrenergic agonist isoproterenol elicits smaller increases in Ca2+
currents, Ca2+ transients and contractions in myocytes from females in
comparison to males [10,12]. This is accompanied by a smaller increase
in isoproterenol-stimulated cAMP levels in female myocytes [12]. How-
ever, whether there are male–female differences in basal cAMP levels
has not been investigated. If basal cAMP is lower in females, this would
be expected to cause less PKA activation, and could explain lower SR
Ca2+ release and EC coupling gain in female myocytes in comparison
to males. Levels of cAMP are critically regulated by phosphodiesterase
(PDE) enzymes, which are responsible for hydrolysis and breakdown
of cyclic nucleotides [13,14]. In hearts from male animals, PDE3 and
PDE4 have been largely implicated in modulating Ca2+ handling and
EC coupling [15–17], though PDE1 and PDE2 have also been suggested
to have minor contributions [18,19]. Whether expression of major PDE
isoforms is similar in females has not yet been investigated.
The objectives of this study were: 1) to determine whether basal dif-
ferences in cAMP levels contribute to sex differences in SR Ca2+ release;
and 2) to investigate the underlying cellular mechanisms responsible
for male–female differences in SR Ca2+ release. Experiments measured
Ca2+ currents, Ca2+ transients, Ca2+ sparks and intracellular cAMP levels
in ventricular myocytes from male and female mice. The effects of
pharmacologically activating or inhibiting the cAMP/PKA pathway on
sex differences in Ca2+ handling properties were examined, as was a
role for PDE. Results indicate that the cAMP/PKA pathway plays a major
role in attenuating SRCa2+ release inmyocytes from females, and suggest
that increased cAMP degradation by PDE4B may be responsible.
2. Materials and methods
An expanded Methods section is available on the online Data
Supplement.
2.1. Isolation of ventricular myocytes
Experiments conformed to the Canadian Council on Animal Care
Guide to the Care and Use of Experimental Animals and were approved
by the Dalhousie University Committee on Laboratory Animals. Adult
C57BL/6 male and female mice (5–10 months) were obtained from
Charles River Laboratories (St. Constant, QC). Ventricular myocytes
were isolated by perfusion of enzymes through the aorta as previously
described [20]. Quiescent rod-shaped myocytes with clear striations
were used in experiments.
2.2. Myocyte Ca2+ handling
Myocytes were incubated with fura-2 acetoxymethyl (AM) (5 μM;
Invitrogen, Burlington, ON) for 20min in darkness, and then superfused
with buffer (pH 7.4; 37 °C).
Transient outward K+ current was inhibited with 4-aminopyridine,
while Na+ current was inhibited with lidocaine and inactivated by a
pre-pulse to −40 mV prior to test pulses. Discontinuous single elec-
trode voltage clamp recordings (sample rate 5–6 kHz) were made
with an Axoclamp 2B ampliﬁer (Molecular Devices, Sunnyvale, CA)
and high resistance microelectrodes (18–28 M Ω) to avoid buffering
internal Ca2+ and to minimize intracellular dialysis. Clampex v8.2software (Molecular Devices) was used to generate protocols. Ca2+
transients were measured with a DeltaRam ﬂuorescence system and
Felix v1.4 software (Photon Technologies International (PTI), Birming-
ham, NJ). An in vitro calibration curvewas used to calculate intracellular
Ca2+ concentrations, as previously described [20,21]. All voltage clamp
protocolswere preceded byﬁve 50ms conditioning pulses from−80 to
0mV(2Hz). Ca2+ currents and transientswere recorded simultaneous-
ly during 250ms test pulses to varying potentials. A single 250 ms volt-
age clamp test step from −40 to 0 mV was used to activate Ca2+
transients and Ca2+ currents in experiments where myocytes were ex-
posed to drugs. Ca2+ current, measured as the difference between peak
current and the end of the test pulse, was normalized to cell capaci-
tance. Ca2+ current decay (tau) was quantiﬁed by ﬁtting traces
with an exponential function and total Ca2+ ﬂux was measured as
the integral of the Ca2+ current. Steady-state activation of the L-
type Ca2+ current was obtained by calculating conductance as: g =
ICa / (V − Erev). Steady-state activation of each cell was ﬁtted with
the Boltzmann equation: d = 1 / {1 + exp[−(VC− Vh) / k]}. SR
Ca2+ content was measured by rapid application (1 s) of caffeine
solution, which was nominally Ca2+- and Na+-free to inhibit extru-
sion of Ca2+ by Na+–Ca2+ exchange.
Ca2+ sparks were recorded in myocytes incubated with ﬂuo-4 AM
(20 μM) as previously described [22]. Cells were placed in a chamber
on a laser scanning confocal microscope (Zeiss LSM 510-Meta, Carl
Zeiss Canada, Toronto, ON) and superfused with buffer (37 °C). Solvent
alone (0.02 and 0.04% DMSO) had no effect on Ca2+ currents, Ca2+
transients, or Ca2+ sparks in males or females.
2.3. Enzyme immunoassay, immunoblotting, and quantitative PCR
Intracellular cAMP levels were determined in isolated ventricular
myocytes treated with control, DMSO solvent control (0.1%), or
forskolin (10 μM), as previously reported [22]. Total RyR2 and
phospho RyR2-S2808 protein levels were determined by immuno-
blotting, as previously described [23]. Polyacrylamide gels (6%)
were loaded with equal amounts of total sample protein (10 μg). Pri-
mary antibodies used were ryanodine receptor (RyR; AbCam, Cam-
bridge, UK; 1:5000) and RyR2 phospho Serine-2808 (RyR2-S2808;
Badrilla, Leeds, UK; 1:2500). Quantitative mRNA expression of PDE
isoforms was measured in ventricles, as described previously [24],
using intron spanning primers for PDE3A, PDE3B, PDE4A, PDE4B
and PDE4D isoforms (Supplemental Table 1). GAPDH was used as a
reference gene.
2.4. Statistical analyses
Sigmaplot (v11.0, Systat Software Inc.) was used for all statistical
analyses and ﬁgures. Differences between means ± S.E.M. were signif-
icant for P b 0.05.
3. Results
3.1. Ca2+ transients are smaller and EC coupling gain is lower in female
myocytes in comparison to males
Experiments were designed to examine sex differences in Ca2+
handling in myocytes frommale and female C57BL/6 mice. Ventricu-
lar myocytes were voltage clamped and basal Ca2+ handling proper-
ties were measured during a single 250 ms test step to 0 mV (Fig. 1A,
top panel). Cell capacitance, a measure of membrane area, was sim-
ilar in male and female myocytes (235.4 ± 12.2 and 215.3 ± 8.9 pF,
P = 0.377). Fig. 1A depicts representative Ca2+ transients (left
panels) and L-type Ca2+ currents (right panels) recorded simulta-
neously in myocytes from a male and a female mouse. Mean data
revealed that Ca2+ transient amplitude was signiﬁcantly smaller in
myocytes from females in comparison to males (Fig. 1B). This was
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Fig. 1.Ca2+ transients and theEC coupling gain are smaller inmyocytes from females in comparison tomales, despite similar L-type Ca2+ current. A. The top panel shows the voltage clamp
protocol, which consisted of conditioning pulses prior to a test step from−40 to 0 mV. Ca2+ transient (left panel) and Ca2+ current (right panel) recordings from male and female
myocytes. B. Ca2+ transients were signiﬁcantly smaller inmyocytes from females. C. Peak Ca2+ current did not differ betweenmales and females. D. Ca2+ current decay, tau, was similar
between the sexes. E. Total Ca2+ ﬂux was similar between the sexes. F. EC coupling gain was lower in females than males. (n = 43 male, 42 female cells; 23 male, 22 female
animals; * denotes P b 0.05).
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both sexes (Fig. 1C). Nor was this a result of differences in the
decay or total ﬂux of the current, as the time constant of inactivation
(tau; Fig. 1D) and the total Ca2+ ﬂux (Fig. 1E) were also similar
between males and females. Typically, the size of the Ca2+ transient
is proportional to the amount of Ca2+ entering the cell upon depolar-
ization [11]. To quantify the ampliﬁcation of Ca2+ signalling and
compare between the sexes, EC coupling gain was calculated as a
ratio of SR Ca2+ release to peak Ca2+ current. Results showed that
gain was lower in females in comparison to males (Fig. 1F). These
ﬁndings demonstrate that, although males and females exhibited
similar Ca2+ currents, females had smaller Ca2+ transients, and
thus lower gain.
Ca2+ transients and Ca2+ currents illustrated in Fig. 1were recorded
during a single voltage clamp step to 0mV. Experiments were designed
to determine if similar sex differences were seen over a range of mem-
brane voltages. Fig. 2A shows Ca2+ transients measured during test
steps to voltages between −40 and +80 mV. Peak Ca2+ transients
were smaller in female myocytes than males (Fig. 2A), as determined
by two-way repeated measures ANOVA. Underlying Ca2+ currents
simultaneously measured in these myocytes did not differ between
the sexes (Fig. 2B). To determine whether there were male–female
differences in the voltage-dependence of activation of the Ca2+ current,steady-state activation curves were constructed. Fig. 2C shows that the
steady-state activation was similar in males and females, as was the
voltage of half-maximal activation (inset). The slope factor for
steady-state activation was also similar in the two groups (4.8 ±
0.2 vs. 5.0 ± 0.2; P = 0.408). These results suggest that male and
female myocytes have similar Ca2+ inﬂux upon depolarization, but
females exhibit smaller Ca2+ transients at physiologically relevant
membrane voltages. EC coupling gain was also lower in females in
comparison to males, and this difference was signiﬁcant over a
physiologically relevant range of membrane voltages (Fig. 2D).
Thus, sex differences in Ca2+ transients and gain are present across
a wide range of physiologically relevant voltages.
3.2. SR Ca2+ sparks are smaller in females, though SR Ca2+ content does
not differ
To determine whether sex differences in Ca2+ transients were at-
tributable to smaller SR Ca2+ release units, theproperties of Ca2+ sparks
were compared in quiescent myocytes from males and females. Fig. 3A
shows representative Ca2+ sparks from male and female myocytes. As
shown in Fig. 3B, spark frequency did not differ between the sexes.
However, Ca2+ sparks in females were signiﬁcantly smaller in ampli-
tude in comparison to males (Fig. 3C). The width and duration of
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maximumwere similar betweenmales and females (Fig. 3D and E). The
time-to-peak of Ca2+ sparks was also similar between the sexes
(Fig. 3F), though the tau of decay was faster in females than males
(Fig. 3G). These results demonstrate that SR Ca2+ release units are
smaller and decay faster in cells from females.
To elucidate whether smaller Ca2+ transients and sparks in female
myocytes could be explained by lower SR Ca2+ stores, SR Ca2+ content
was examinedwith rapid application of caffeine (Fig. 4A). Caffeine tran-
sient recordings from male and female myocytes are shown in Fig. 4A.
Mean data revealed no sex difference in SR Ca2+ content, as shown in
Fig. 4B. To quantify the amount of SR Ca2+ released as a percentage of
the Ca2+ available in the SR, fractional release (Ca2+ transient/caffeine
transient)was compared in the twogroups. Fig. 4C shows that fractional
release was lower in myocytes from females in comparison to males.
Resting Ca2+ could also affect the gain of EC coupling, though diastolic
Ca2+ levels did not differ between the sexes (Fig. 4D). These results in-
dicate that smaller Ca2+ sparks and transients in females are not due to
sex differences in SR Ca2+ content or diastolic Ca2+ concentration.
3.3. Intracellular cAMP levels are lower in females, and inhibition of PKA at-
tenuates sex differences in SR Ca2+ release
Experiments were then designed to investigate contributions of the
cAMP/PKA pathway in modulating SR Ca2+ release in males and
females. Intracellular cAMP levels were measured in ventricular
myocytes, and Fig. 5A shows that, under basal conditions, female cells
had signiﬁcantly lower levels of cAMP in comparison to males. Lower
intracellular cAMP would cause less PKA activation and result in lower
levels of phosphorylation of EC coupling targets in females than in
males. To examine whether this contributed to sex differences in SRCa2+ handling, experiments were performed with the selective PKA
inhibitor H-89 (2 μM) [25], and results are presented as% ofmale control
to facilitate comparisons between groups. Fig. 5B depicts representative
Ca2+ transients and Ca2+ currents obtained in H-89 during a single
250 ms voltage clamp step from −40 to 0 mV. The inhibition of PKA
reduced Ca2+ transients in both sexes, and importantly, eliminated the
sex difference that was seen under basal conditions (Fig. 5C, P = 0.646).
H-89 reduced Ca2+ current to a similar extent in myocytes from both
sexes (Fig. 5C). Importantly, the male–female difference in basal gain
was abolished (Fig. 5C, P = 0.100). These ﬁndings suggest that the
cAMP/PKA pathway plays a key role in mediating sex differences in
basal gain, as cAMP levels were lower in females and inhibition of PKA
attenuated differences in Ca2+ transient amplitude and gain between
males and females.
To determinewhether H-89would eliminate sex differences in sub-
cellular Ca2+ release, individual SR Ca2+ sparks were measured in the
absence and presence of 2 μM H-89. Fig. 5B shows examples of sparks
with H-89 in both sexes. The inhibition of PKA eliminated the male–
female difference in basal Ca2+ spark amplitude by reducing spark
size to a similar extent in both sexes (Fig. 5D). In addition, H-89 attenu-
ated the difference in Ca2+ spark decay between the sexes (Fig. 5D). The
frequency of Ca2+ sparks was also dramatically reduced by H-89, but
remained similar in males and females (Fig. 5D). These results demon-
strate that male–female differences in individual spark amplitude and
decay are no longer present when PKA is inhibited.
SR Ca2+ content is an important determinant of the amount of Ca2+
released via ryanodine receptors (RyRs), and higher SR stores increases
the frequency of Ca2+ sparks [26]. As such, we sought to determine
whether inhibition of PKA affected SR Ca2+ release by altering SR
Ca2+ content. However, SR content was unaffected by H-89, as shown
by mean caffeine transient amplitude (Fig. 5E). Interestingly, H-89 did
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abrogated the basal sex difference (Fig. 5E). Furthermore, while H-89
had no effect on diastolic Ca2+ levels in males, it reduced diastolic
Ca2+ in female cells (Fig. 5E). These ﬁndings show that pharmacological
inhibition of the cAMP/PKApathway, which blocks sex differences in in-
tracellular cAMP, eliminated differences in SR Ca2+ release, fractional
Ca2+ release and EC coupling gain between males and females.
It is possible that inhibition of PKA decreases the amplitude of Ca2+
sparks by decreasing the phosphorylation of RyR2 by PKA. To determine
if PKA inhibition attenuatedmale–female differences in Ca2+ transients
and SR Ca2+ sparks by altering phosphorylation of RyR2, immunoblot-
ting for phospho RyR2-S2808 was performed. Total RyR2 (Fig. 6A) and
phospho RyR2-S2808 (Fig. 6B) did not differ between males and
females under basal conditions, and H-89 did not signiﬁcantly affect
levels of either protein in males or females. As shown in Fig. 6C, the
ratio of phospho RyR2-S2808 to total RyR2 was also similar between
males and females under basal conditions. However, the inhibition ofPKA with H-89 resulted in a signiﬁcant reduction in the ratio of RyR2-
S2808 to total in males, but had no effect in females.
3.4. Stimulation of adenylyl cyclase removes sex differences in EC coupling
gain
To determine if responses to stimulation of cAMP production differed
between the sexes, myocytes were exposed to a maximal concentration
of the adenylyl cyclase activator, forskolin (10 μM) [22,27,28]. Forskolin
increased intracellular cAMP to a similar level in both sexes (Fig. 7A). Ex-
periments were then performed to determine if forskolin would also at-
tenuate sex differences in EC coupling. Fig. 7B depicts representative
Ca2+ transients and Ca2+ currents measured in the presence of forskolin
during a 250 ms voltage clamp step from−40 to 0 mV. Ca2+ transient
amplitude was increased by forskolin in both sexes, and was no longer
smaller in females (Fig. 7C, P = 0.229). Ca2+ current was also increased
by forskolin and remained similar between the sexes (Fig. 7C). As forskolin
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effect on EC coupling gain, although it abolished the male–female
difference that was present under basal conditions (Fig. 7C, P = 0.389).
To elucidate whether forskolin affected subcellular Ca2+ release
units, Ca2+ sparks were compared in male and female myocytes in
the absence and presence of 10 μM forskolin. Examples of sparks mea-
sured in forskolin are shown in Fig. 7B. Forskolin increased the ampli-
tude of Ca2+ sparks in both groups and reversed the sex difference
observed under basal conditions (Fig. 7D). Ca2+ spark decaywas not af-
fected by forskolin, but the sex difference observed under basal condi-
tions was no longer present (Fig. 7D, P = 0.093). The frequency of
Ca2+ sparks was unaffected by activation of adenylyl cyclase in males
or females (Fig. 7D). These results suggest that, when intracellular
cAMP is increased to similar levels in males and females, differences in
Ca2+ transients, EC coupling gain, and individual SR Ca2+ sparks are
eliminated.
3.5. PDE4B expression is increased in females, and PDE4 inhibition abolishes
sex differences in EC coupling gain
To examine the mechanisms underlying sex differences in intracel-
lular cAMP levels, experiments were performed to determine if degra-
dation of cAMP differed between the sexes. Quantitative PCR was
performed to measure mRNA levels of PDE, the enzyme responsible
for breaking down cAMP. Speciﬁcally, PDE3 and PDE4 families were ex-
amined, as these are themajor isoforms expressed in the ventricles [16,
29]. Fig. 8A shows that ventricles from male and female mice had a
similar pattern of expression of PDE3A and PDE3B, as well as PDE4A
and PDE4D. However, PDE4B expression was signiﬁcantly higher in
females in comparison to males (Fig. 8A). This could increase cAMP
degradation in the female heart and lead to lower levels of cAMP in
comparison to males.
To determine whether an increase in the expression of PDE4B in
females could account for basalmale–female differences in EC coupling,
experiments were performed in the presence of the selective PDE4
inhibitor rolipram (10 μM). Voltage clamp experiments with a test
step from−40 to 0 mV revealed that inhibition of PDE4 increased the
amplitude of Ca2+ transients in female myocytes, but not in males,
thus eliminating the basal sex difference (Fig. 8B, P = 0.403).
While rolipram had no effect on L-type Ca2+ current in myocytes
from either sex, it increased EC coupling gain in females (P = 0.05)and eliminated the male–female difference in gain under basal
conditions (Fig. 8B, P = 0.540). These results demonstrate that
females have increased expression of PDE4B, which may reduce in-
tracellular levels of cAMP and contribute to smaller Ca2+ transients
and reduced EC coupling gain in female myocytes.
Experiments were then performed to determine whether PDE4
inhibition would abolish sex differences in individual SR Ca2+
sparks. In the presence of 10 μM rolipram, Ca2+ spark amplitude
was increased in both sexes, although sparks remained smaller in
female myocytes in comparison to males (Fig. 8C). Rolipram reduced
Ca2+ spark decay in males and increased decay rates in females, so
the sex difference present under basal conditions was reversed and
sparks were prolonged in females (Fig. 8C). Spark frequency was
unaffected by rolipram in either males or females (Fig. 8C). These
results show that inhibition of PDE4 increases the amplitude and
duration of Ca2+ sparks in females, which may contribute to the
increase in Ca2+ transient amplitude and gain caused by rolipram.
4. Discussion
The goal of this study was to examine sex differences in myocardial
Ca2+ handling in a murine model and discern a role for the cAMP/PKA
pathway in mediating differences in SR Ca2+ release between males
and females. Results indicate that myocytes from female mice had
smaller Ca2+ transients, as well as smaller subcellular SR Ca2+ sparks
in comparison to males. The reduction in SR Ca2+ release in cells from
females occurred despite similar Ca2+ current, SR Ca2+ content and
diastolic Ca2+ levels between the sexes. As such, females had lower EC
coupling gain than males. We also found that basal cAMP levels were
lower in females, which corresponded to an increase in the expression
of PDE4B in comparison to males. Interestingly, both adenylyl cyclase
activation and PDE4 inhibition eliminated differences in Ca2+ transient
amplitude and EC coupling gain between the sexes. Importantly, inhibi-
tion of PKA decreased the ratio of phosphorylated to total RyR2 inmales
and had no effect in females. PKA inhibition also abolishedmale–female
differences in Ca2+ transients, EC coupling gain, Ca2+ sparks, and
fractional SR Ca2+ release. Overall, these observations suggest that the
lower SR Ca2+ release and EC coupling gain characteristic of female
cardiomyocytes is due to increased cAMP hydrolysis in females, which
would likely result in less phosphorylation of SR targets, particularly
RyR2, by PKA and thus alter SR Ca2+ handling.
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168 R.J. Parks et al. / Journal of Molecular and Cellular Cardiology 75 (2014) 162–173Our previous study in rats showed that ventricular myocytes from
females have smaller Ca2+ transients and Ca2+ sparks in comparison to
males, as well as lower EC coupling gain [8]. However, whether similar
sex differences are seen in cardiomyocytes from mice is controversial
[30,31]. This study addressed the issue of whether similar sex differences
are observed in a murine model, as these ﬁndings could enable futurework with genetically-modiﬁed models. A major observation made in
the present study is that basal Ca2+ transients are also smaller in ventric-
ular myocytes from female C57BL/6 mice in comparison to males, while
simultaneously measured L-type Ca2+ currents did not differ, which re-
sulted in lower gain in females. Previous studies that have measured
Ca2+ transients or Ca2+ currents independently have reported similar
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show that male–female differences in Ca2+ current are unlikely to be
responsible for less SR Ca2+ release in females in comparison to males.
Our results indicate that male–female differences in SR Ca2+ release
are not due to differing SR Ca2+ content or cytosolic Ca2+ concentration,
as both parameters were similar between the sexes. These ﬁndings are
in agreement with a number of studies in rats and other rodents that
have reported similar diastolic and SR Ca2+ betweenmales and females
[8,10,30,34]. The present study also found that Ca2+ sparkswere smaller
in amplitude anddecayedmore quickly inmyocytes from femalemice incomparison to males, as observed previously in rats [8]. These smaller
and faster subcellular Ca2+ release units in myocytes from females
may sum to form smaller Ca2+ transients than in males. As these mea-
surements were obtained from quiescent myocytes and are indepen-
dent of Ca2+ current activation, the amplitude of Ca2+ sparks is
indicative of the intrinsic gating of ryanodine receptors [35]. Our results,
taken together with the report by Farrell et al. [8], suggest that smaller
Ca2+ sparks and lower EC coupling gain are fundamental properties of
female cardiomyocytes.
A key ﬁnding in our study is that, under basal conditions, intracellu-
lar cAMP levels are smaller in myocytes from females in comparison to
males. Lower cAMP levels in female myocytes would be expected to
cause less activation of PKA, whichwould result in less phosphorylation
of EC coupling components in comparison to males. The present study
examined the functional consequences of PKA inhibition on Ca2+
handling and made the novel observation that H-89 abolished sex
differences in both subcellular Ca2+ sparks and Ca2+ transients,
resulting in similar EC coupling gain between males and females. This
was not due to an effect of PKA inhibition on SR Ca2+ stores, and there-
fore, fractional release was similar between the sexes with H-89.
Furthermore, even though Ca2+ channels are phosphorylated under
the basal state, sex differences in Ca2+ current are not involved as inhi-
bition of PKA reduced current in males and females to a similar extent.
Our group has previously identiﬁed a role for PKA in maintaining SR
Ca2+ release in female myocytes in the absence of β-adrenergic stimu-
lation [22]. The present study suggests that a similar or even larger role
exists for PKA in regulating basal SR Ca2+ release in male myocytes.
Together, these results suggest that lower cAMP levels in females
cause less basal activation of PKA, which in turn attenuates Ca2+ sparks,
and thus Ca2+ transient amplitude and EC coupling gain.
Our results show that basal RyR2 protein levels do not differ in
ventricles from male and female mice. Interestingly, we also found
that there was no sex difference in RyR2 phosphorylation at S2808
under basal conditions, which was unexpected given the difference in
SR Ca2+ release. The basis for this is unclear, but could be related to
male–female differences in PKA-mediated phosphorylation at another
site, such as S2030 [36]. Nonetheless, our data clearly show that inhibi-
tion of PKA caused a marked reduction in the ratio of phospho RyR2-
S2808 to total RyR2 in males, but had no effect in females. This male-
selective effect of PKA inhibition on RyR2 phosphorylation could explain
why H-89 abolishes sex differences in Ca2+ transients, Ca2+ sparks and
the gain of SR Ca2+ release. It is possible that there are higher local levels
of cAMP around RyR2 in males than in females and that this compart-
mentalization of cAMP contributes to sex differences in SR Ca2+ release.
Sex differences in response to stimulation of the cAMP/PKApathway
were examined with a maximal concentration of forskolin, which
resulted in similar intracellular cAMP between male and female
cardiomyocytes. Previous studies with β-adrenergic receptor agonists
have found no male–female difference in cAMP levels [12,37], though
males may have a minor increase in adenylyl cyclase activity [38]. Im-
portantly, the present study found that, although forskolin increased
Ca2+ currents in both males and females, it abolished differences in
Ca2+ transients, Ca2+ sparks, and EC coupling gain between males
and females. Nichols et al. [39] have shown that forskolin (0.1 μM)
increases RyR2 phosphorylation at S2808. Though controversial,
previous work has suggested that PKA phosphorylation of RyR2
increases openprobability and thus SR Ca2+ release [40–43]. Our results
suggest that exposingmale and femalemyocytes to similar intracellular
cAMP attenuates sex differences in SR Ca2+ release, which could be due
to similar levels of PKA-mediated phosphorylation of RyR2.
There is some evidence that the levels of CaV1.2 protein, which is a
subunit of the L-type Ca2+ channel, are higher in females in comparison
to males in rat and rabbit models [44,45]. However, as reviewed by
Parks and Howlett [46], there is a general consensus in the literature
that Ca2+ current does not differ between male and female rodents.
The present study shows that Ca2+ current remains similar between
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cyclasewith forskolin. These ﬁndings suggest that L-type Ca2+ channels
are exposed to similar cAMP levels under basal conditions and upon
activation or inhibition of the cAMP/PKA pathway. It is possible that
compartmentalization of functional cAMP pools around L-type Ca2+
channels is responsible for comparable Ca2+ currents between the
sexes. Male–female differences may exist in other post-translational
modiﬁcations of L-type Ca2+ channels, which could negate the increase
in Ca2+ channel expression that has been shown in female rodent
models.
Previous studies using only male rodents have implicated speciﬁc
PDE isoforms in controlling functional compartments of cAMP within
cardiomyocytes [47]. Importantly, ours is the ﬁrst study to examine
the expression pattern of PDE isoforms in ventricles from female
rodents, and to compare with levels in males. PDE3 and PDE4 were
examined, as these are the two main families implicated in the regula-
tion of cardiac contractile function [16,29,47,48]. We made the novel
observation that PDE4B mRNA expression was increased in female
ventricles in comparison to males. Otherwise, the pattern of expression
in females andmaleswas similar to previous results obtained in isolated
myocytes orwhole ventricles ofmice and rats [15,27]. Speciﬁcally, stud-
ies have suggested that PDE4B is complexed with L-type Ca2+ channels[49], while PDE4D and PDE3A have been shown to localize to RyR2 and
SERCA2a [50–53]. It is possible that compartmentalization differs in
females in comparison to males, and that an increase in the expression
of PDE4B in females could increase breakdown of a speciﬁc functional
pool of cAMP, perhaps around RyR2 as suggested by the results of the
present study. Future studies to investigate PDE4B localization in female
myocytes are warranted, as this could be involved in lower SR Ca2+ re-
lease in females.
The present study examined the effect of inhibiting all PDE4 isoforms,
and determined that rolipram abolished differences in Ca2+ transients
and EC coupling gain between myocytes from males and females. Many
previous studies have reported no inotropic effect of rolipram on
cardiomyocytes [24,50,54], however, all of these studies have examined
myocytes from male animals only. Our results indicate that rolipram
increases Ca2+ transient amplitude selectively in female myocytes to a
level similar to males, thus resulting in comparable EC coupling gain
between the sexes. Rolipram also increased the amplitude of Ca2+ sparks
in both male and female cells, although sparks remained smaller in
females. Interestingly, inhibition of PDE4 reduced the rate of decay of
individual sparks in males, while prolonging decay in females. Therefore,
it is possible that although sparks remain smaller in females, PDE4 inhibi-
tion prolongs spark duration in comparison to males, which would result
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has been shown to be regulated by the intrinsic gating of RyR [35], which
may become similar in males and females upon inhibition of PDE4.
A limitation to our study is that experiments measured total cellular
cAMP, and therefore did not take into account potential differences that
may exist in compartmentalization of cAMP within male and female
cardiomyocytes. However, our results do demonstrate an important dif-
ference that exists in total cAMP content, and thus overall PKA activity
between males and females. It is also possible that other PDE isoforms
contribute to sex differences in SR Ca2+ release. For example, recent
ﬁndings have suggested that PDE2 may play a role in regulating basal
EC coupling in the heart [19], although the impact on EC coupling was
modest and was only examined in males. The present study used high
resistance microelectrodes and discontinuous single electrode voltage
clamp (switch clamp) to measure Ca2+ current, as in many previous
studies by our group and others (e.g. [22,30,55–57]). This has the
advantage of limiting dialysis of important intracellular components
such as cAMP and avoids buffering intracellular Ca2+ levels. Although
access resistance is higher with this approach than with patch pipettes,
we continuously monitored the output of the switching circuit during
switch clamp to ensure adequate settling time for accurate voltagemea-
surement and optimal accuracy of voltage control. An alternativeapproach to minimize internal dialysis would be to use the perforated
patch-clamp technique, although this technique also has higher access
resistance than patch pipettes and so is often used in conjunction with
switch clamp [58]. Another limitation to consider is that experiments
were performed in C57BL/6 mice, and thus results cannot be directly
applied to humans. Echocardiography and working heart studies in
mice have reported either no sex difference or reduced ejection fraction
in female in comparison to male mice [59,60]. However, studies in
humans have identiﬁed higher ejection fraction at rest in women than
men [1,2]. These differing results suggest that species differences may
exist between mice and humans, which could be due to variations in
autonomic tone.
In conclusion, these results suggest that the cAMP/PKA pathway
plays a role in sex differences in SR Ca2+ release by attenuating the
magnitude and duration of individual Ca2+ release units in female
myocytes. This study suggests that increased degradation of cAMP by
PDE4B in females may result in sex differences in the activity of PKA.
Whether sex steroid hormones are involved in these male–female
differences is not yet understood. However, testosterone has been
shown to inhibit PDE activity in the ventricles of male rats [61] and
this could explain the higher levels of cAMP observed in male cells.
Interestingly, results from Kravtsov et al. [62] suggest that ovariectomy
172 R.J. Parks et al. / Journal of Molecular and Cellular Cardiology 75 (2014) 162–173increases PKA activity in female rats. Together with our study, this
suggests that oestrogen may suppress SR Ca2+ release, which is at
least partly due to decreased signalling via the cAMP/PKA pathway. Ul-
timately, these ﬁndings imply that female hearts may have limited pos-
itive inotropic responses to stimulation of the cAMP/PKA pathway,
which could be due to lower basal activity in female ventricular
myocytes. Less SR Ca2+ release in females would limit Ca2+ overload
while simultaneously limiting inotropic responses in conditions of
higher demand. This could be protective against cardiovascular disease
resulting fromhigh Ca2+ levels, however cardioprotectionmay occur at
the expense of increased inotropy.
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